cytotox
epitopespecif
cell
usual
measur
indirectli
product
exist
assay
directli
measur
activ
limit
mainli
measur
two
specif
singl
reaction
develop
multiplex
cytotox
assay
allow
direct
simultan
measur
differ
specif
cell
singl
reaction
greatli
reduc
amount
start
clinic
materi
systemat
screen
cell
epitop
addit
greatli
enhanc
capac
enabl
incorpor
irrelev
epitop
determin
nonspecif
kill
activ
cell
therebi
allow
measur
actual
epitopespecif
cytotox
activ
techniqu
shown
use
studi
human
mous
cell
besid
result
human
pbmc
three
independ
infecti
anim
model
mer
influenza
malaria
reveal
express
epitopespecif
cell
alway
correl
cellkil
potenti
highlight
need
use
cytotox
assay
specif
context
eg
evalu
vaccin
candid
overal
approach
open
new
possibl
comprehens
analys
cell
cytotox
practic
manner
cytotox
epitopespecif
cell
usual
measur
indirectli
product
exist
assay
directli
measur
activ
limit
mainli
measur
two
specif
singl
reaction
develop
multiplex
cytotox
assay
allow
direct
simultan
measur
differ
specif
cell
singl
reaction
greatli
reduc
amount
start
clinic
materi
systemat
screen
cell
epitop
addit
greatli
enhanc
capac
enabl
incorpor
irrelev
epitop
determin
nonspecif
kill
activ
cell
therebi
allow
measur
actual
epitopespecif
cytotox
activ
techniqu
shown
use
studi
human
mous
cell
besid
result
human
pbmc
three
independ
infecti
anim
model
mer
influenza
malaria
reveal
express
epitopespecif
cell
alway
correl
cellkil
potenti
highlight
need
use
cytotox
assay
specif
context
eg
evalu
vaccin
candid
overal
approach
open
new
possibl
comprehens
analys
cell
cytotox
practic
manner
prime
activ
antigenpres
cell
secondari
lymphoid
organ
epitopespecif
cell
expand
number
migrat
site
infect
kill
infect
cell
cell
also
form
part
memori
respons
rapidli
expand
number
elimin
pathogen
secondari
challeng
also
cell
recogn
tumor
antigen
present
cancer
cell
erad
metastas
cytotox
cell
requir
direct
contact
target
cell
although
capabl
cell
elimin
target
cell
remain
uncertain
regardless
celltocel
contact
enabl
cell
releas
cytotox
granul
death
ligand
therebi
kill
target
cell
interferongamma
one
critic
cytokin
establish
effect
immun
respons
context
cell
cytokin
help
drive
polar
cell
respons
h
direct
overal
cell
respons
toward
cellmedi
immun
cell
activ
subset
start
produc
rapidli
domin
epitopespecif
cell
expand
preferenti
subdomin
one
product
activ
cell
also
promot
h
polar
enhanc
cell
motil
cytotox
exert
antivir
immun
wide
varieti
cell
receptor
signal
also
play
vital
role
regul
contract
effector
cell
clearanc
primari
infect
despit
multipl
function
produc
activ
epitopespecif
cell
wide
use
indirect
marker
demonstr
function
efficaci
epitopespecif
cell
exampl
assay
measur
produc
cell
highli
robust
eg
intracellular
cytokin
stain
ic
often
use
surrog
marker
screen
assay
identifi
potenti
cytotox
cell
epitop
howev
one
note
relationship
two
paramet
necessarili
correl
cytotox
cell
cognat
target
measur
directli
initi
assay
radioact
label
target
cell
mostli
use
fluorescencebas
method
sinc
supplant
radioact
label
method
due
higher
sensit
better
safeti
profil
howev
assay
typic
use
singl
target
format
allow
measur
cytotox
potenti
one
two
cell
attribut
approach
highli
robust
limit
potenti
use
largescal
screen
studi
need
test
mani
cell
epitop
amount
start
materi
mice
human
pbmc
need
inevit
increas
substanti
may
pose
difficulti
conduct
comprehens
analys
studi
demonstr
feasibl
measur
cytotox
activ
twentyfour
specif
use
three
fluoresc
dye
singl
reaction
therebi
increas
multiplex
capabl
screen
multipl
cell
epitop
simultan
use
cell
human
pbmc
analyz
previous
known
epitop
influenza
virus
vitro
show
epitop
elicit
robust
cytotox
respons
mous
model
demonstr
method
allow
screen
cell
harvest
differ
anatom
site
approach
allow
accur
measur
cell
kill
attribut
cognat
cell
demonstr
express
epitopespecif
cell
necessarili
correl
cytotox
potenti
result
highlight
multiplex
assay
potenti
use
identifi
potent
cytotox
cell
epitop
besid
epitop
differenti
effect
product
cytotox
activ
cell
identifi
approach
rapid
manner
peptid
puriti
purchas
genscript
piscataway
nj
reconstitut
mgml
dimethyl
sulphoxid
dmso
store
c
healthi
donor
patient
provid
written
inform
consent
particip
studi
ethic
approv
obtain
human
research
ethic
committe
univers
hong
kong
monash
health
royal
melbourn
hospit
local
refer
number
blood
sampl
subject
screen
bloodborn
pathogen
sent
human
leukocyt
antigen
hla
type
patient
blood
sampl
collect
sodium
heparin
tube
pbmc
isol
previous
describ
briefli
blood
dilut
vv
pb
overlaid
sigmaaldrich
st
loui
mo
centrifug
g
min
without
brake
isol
pbmc
wash
pb
resuspend
dmso
liquid
nitrogen
storag
sixto
eightweekold
balbcj
human
dipeptidyl
knockin
mice
background
use
experi
mice
bred
specificpathogenfre
condit
anim
experi
procedur
approv
follow
vaccinia
viru
carri
np
ha
na
gene
human
previous
report
us
use
experiment
vaccin
mice
anesthet
given
x
pfu
vaccin
intranas
rout
twice
week
apart
three
week
second
vaccin
mice
challeng
mld
apuerto
intranas
rout
weight
loss
surviv
mice
follow
week
plasmodium
berghei
anka
clone
pba
plasmodium
berghei
parasit
passag
mice
infect
erythrocyt
resuspend
alsev
solut
store
liquid
nitrogen
infect
mice
infect
erythrocyt
inject
intraperiton
rout
parasitaemia
monitor
flow
cytometri
merscov
experi
carri
univers
iowa
facil
mice
infect
pfu
human
isol
merscov
merscovemc
mice
challeng
week
pfu
mouseadapt
strain
merscov
spleen
mice
dissoci
use
cell
strainer
syring
piston
releas
splenocyt
rpmi
complet
medium
supplement
fetal
bovin
serum
fb
uml
penicillinstreptomycin
thermofish
scientif
waltham
splenocyt
resuspend
ack
lysi
buffer
mm
nh
cl
mm
khco
mm
edta
chemic
sigmaaldrich
least
minut
wash
rpmi
complet
medium
splenocyt
split
group
puls
relev
peptid
final
concentr
mgml
treat
cell
label
uniqu
combin
celltrack
cmfda
cmtmr
deep
red
dye
thermofish
scientif
tabl
wash
rpmi
complet
media
equal
number
label
cell
group
combin
transfer
recipi
mice
total
volum
pb
intranas
retroorbit
rout
respect
h
recipi
mice
sacrif
harvest
donor
splenocyt
bronchoalveolar
lavag
label
livedead
fixabl
violet
stain
thermofish
scientif
acquisit
flow
cytometri
thaw
pbmc
wash
twice
rpmi
complet
medium
resuspend
ml
fresh
medium
ml
falcon
tube
left
recov
c
co
overnight
horizont
tilt
loos
cap
recoveri
cell
split
two
group
one
group
treat
cell
isol
kit
group
treat
nanobead
deplet
biolegend
san
diego
ca
target
cell
obtain
neg
fraction
latter
group
split
group
peptid
puls
dye
label
describ
earlier
equal
number
cell
group
combin
togeth
split
two
group
one
group
mix
isol
cell
group
without
cell
seed
flatbottom
plate
incub
c
co
overnight
next
day
cell
label
livedead
fixabl
near
ir
stain
thermofish
scientif
acquisit
use
flow
cytomet
splenocyt
mice
cell
seed
togeth
mgml
mous
biolegend
bd
golgiplug
becton
dickinson
franklin
lake
nj
brefeldin
thermofish
scientif
peptid
tissu
cultur
plate
follow
incub
c
co
h
plasmodium
studi
mous
addit
omit
stain
zombi
aqua
fixabl
viabil
kit
biolegend
min
wash
follow
antibodi
stain
min
select
follow
panel
purifi
clone
pedazzl
clone
brilliant
violet
clone
clone
clone
clone
yt
biolegend
wash
cell
fix
formaldehyd
permeabil
saponin
sigmaaldrich
per
buffer
bd
bioscienc
follow
stain
fitc
clone
biolegendebiosci
formula
calcul
cytotox
antigenspecif
cell
follow
mannwhitney
utest
use
analys
statist
signific
two
group
comparison
two
group
oneway
analysi
varianc
anova
use
sampl
data
follow
normal
distribut
otherwis
kruskalw
test
dunn
posttest
use
dunnett
dunn
multipl
comparison
perform
irrelev
control
ova
mog
design
control
group
flow
cytometr
analysi
carri
flowjo
treestar
ashland
calcul
perform
prism
graphpad
la
jolla
ca
contrast
convent
method
use
singl
cell
label
dye
eg
cmfda
creat
two
distinct
target
popul
flow
acquisit
figur
first
explor
possibl
combin
three
differ
label
dye
exponenti
increas
number
target
popul
distinguish
figur
strategi
inspir
use
multicolorcod
mhc
multim
test
differ
antigenspecif
tcell
respons
singl
sampl
modifi
concentr
dye
differ
group
donor
cell
creat
tabl
equal
number
cell
group
combin
transfer
recipi
mice
intraven
rout
differ
group
donor
cell
could
identifi
flow
cytometri
figur
clear
demarc
donor
group
rais
possibl
directli
measur
cytotox
multipl
cell
specif
simultan
singl
mous
see
possibl
sharp
contrast
convent
method
requir
one
mous
test
singl
cell
epitop
previous
develop
vacciniabas
influenza
viru
iav
vaccin
henceforth
call
vax
express
five
iav
gene
human
gene
mice
experiment
vaccin
known
induc
robust
respons
mice
mice
vaccin
twice
vax
via
intranas
rout
could
fulli
protect
lethal
heterolog
influenza
viru
challeng
mld
wherea
unvaccin
mice
succumb
challeng
figur
use
anim
model
evalu
multiplex
vivo
cytotox
assay
divid
mice
three
group
subject
differ
treatment
figur
treatment
vax
vaccin
follow
viru
challeng
viru
challeng
day
postchalleng
prepar
donor
splenocyt
unrel
mice
divid
eight
group
group
donor
cell
puls
label
specif
combin
peptid
dye
tabl
treat
donor
cell
transfer
mous
group
via
intraven
intranas
rout
figur
upper
lower
panel
recov
recipi
mice
follow
day
shown
figur
could
identifi
label
cell
distinguish
experiment
condit
furthermor
donor
cell
puls
influenza
epitop
cmfda
cmtmr
experienc
high
level
cytolysi
vaccin
mice
upon
challeng
influenza
figur
highlight
middl
panel
figur
unvaccin
mice
howev
cmtmr
control
group
experienc
signific
cytolysi
spleen
bronchoalveolar
lavag
unvaccin
mice
effect
pronounc
latter
tissu
compart
figur
left
vs
right
panel
observ
suggest
inflammatori
microenviron
contribut
substanti
nonspecif
kill
unprotect
mice
proinflammatori
milieu
known
induc
fa
receptor
express
differ
cell
other
shown
bystand
cell
lysi
activ
cell
occur
fasldepend
manner
thu
believ
nonspecif
cytolysi
activ
cell
model
could
occur
similarli
also
believ
bystand
kill
target
cell
due
dysregul
inflamm
result
iav
infect
also
extend
cell
label
iav
epitop
thu
inclus
irrelev
epitop
multiplex
assay
provid
uniqu
opportun
quantit
bystand
kill
effect
consequ
use
data
point
individu
mice
normal
rest
correspond
data
point
obtain
figur
normal
data
clearli
show
cytolysi
influenza
epitop
also
elev
lung
mucosa
vaccin
mice
analyz
cytotox
multipl
epitopespecif
human
cell
simultan
vitro
next
test
potenti
multiplex
approach
use
cell
harvest
human
pbmc
obtain
frozen
pbmc
sampl
hlaa
healthi
individu
influenzainfect
patient
purifi
cell
also
harvest
homolog
cell
correspond
sampl
use
target
cell
assay
target
cell
divid
group
puls
differ
hlaa
influenza
viru
epitop
tabl
epitop
experiment
known
induc
influenzaspecif
cell
respons
hlaa
individu
influenza
research
databas
immun
epitop
databas
peptidepuls
target
group
differenti
label
uniqu
combin
fluoresc
marker
pool
togeth
split
equal
two
group
one
group
incub
togeth
homolog
cell
group
without
latter
group
serv
popul
essenti
calcul
epitopespecif
cell
cytotox
tabl
inocul
recipi
mice
reharvest
next
day
analyz
remain
target
cell
repres
flow
plot
mice
differ
experiment
group
shown
depict
gate
strategi
identifi
correspond
donor
cell
group
correspond
posit
target
cell
treat
dmso
highlight
top
right
panel
mice
exampl
de
analysi
cytolyt
activ
specif
cell
e
normal
shown
p
mannwhitney
utest
sixteen
test
iav
epitop
six
pa
np
np
could
evok
signific
level
cytotox
cognat
cell
healthi
individu
figur
hospit
patient
acut
influenza
figur
six
cytotox
cell
epitop
infect
individu
consist
elicit
stronger
respons
healthi
individu
oneway
anova
holmsidak
postcomparison
p
henc
apart
identifi
multipl
epitopespecif
cell
elicit
cytotox
toward
target
simultan
result
multiplex
vitro
cytotox
assay
correl
immun
statu
individu
ie
rapid
prolifer
influenzaspecif
cell
infect
individu
led
elev
level
cytotox
activ
ebola
circul
region
pbmc
donor
resid
reason
hlaa
ebola
viru
epitop
ebo
could
serv
appropri
irrelev
epitop
demonstr
specif
multiplex
cytotox
assay
well
set
baselin
comparison
expect
cytotox
activ
ebo
could
detect
prove
specif
multiplex
assay
test
human
cell
blood
influenza
viru
epitop
use
human
studi
previous
shown
stimul
cell
respons
variou
immun
assay
tabl
surpris
find
minor
epitop
elicit
cytotox
kill
cognat
cell
hlatyp
pbmc
sampl
highli
limit
difficult
us
studi
phenomenon
comprehens
therefor
use
differ
anim
model
test
whether
cytotox
epitopespecif
cell
differ
correspond
product
first
use
vaccin
mous
model
describ
check
phenomenon
expand
number
epitop
test
search
influenza
research
databas
bind
epitop
variant
found
subtyp
avail
select
total
epitop
combin
screen
tabl
also
chose
perform
multiplex
vivo
cytotox
assay
assay
figur
separ
experi
order
avoid
issu
spillov
signal
brightli
label
donor
splenocyt
result
overlaid
onto
singl
graph
allow
better
visual
comparison
figur
viral
epitop
highlight
gray
variant
epitop
dot
box
vaccin
mice
subject
lethal
challeng
immunodomin
epitop
consist
produc
robust
respons
assay
figur
left
howev
follow
epitop
give
concord
result
figur
arrow
especi
peptid
elicit
signific
posit
respons
cytotox
assay
assay
measur
express
interestingli
except
iav
variant
epitop
present
subtyp
elicit
similar
cytotox
express
cell
correspond
homolog
present
suggest
cell
may
toler
small
chang
epitop
sequenc
enabl
target
cell
infect
iav
subtyp
unvaccin
mice
cytotox
significantli
elev
upon
lethal
challeng
albeit
level
seen
vaccin
mice
figur
importantli
intracellular
stain
show
signific
differ
test
peptid
mous
work
observ
appar
discrep
product
common
marker
cell
activ
actual
cytotox
iavspecif
cell
wonder
could
observ
phenomenon
diseas
model
answer
use
pathogen
malaria
model
evalu
malaria
parasit
plasmodium
berghei
anka
pba
caus
sever
neurolog
complic
term
experiment
cerebr
malaria
suscept
mice
day
postinfect
mice
infect
pba
subject
assay
eleven
previous
known
b
malaria
epitop
tabl
pbainfect
mice
cell
display
significantli
elev
kill
activ
interestingli
cell
specif
epitop
regist
signific
increas
product
figur
similar
result
also
occur
differ
parasit
strain
use
infect
mice
figur
addit
investig
phenomenon
mous
model
merscov
infect
model
mice
infect
merscovemc
week
mice
challeng
pfu
mouseadapt
strain
merscov
peak
cell
respons
splenocyt
harvest
assay
epitopespecif
cell
activ
epitop
shown
tabl
express
vivo
cytotox
assay
shown
figur
cell
recogn
test
figur
feasibl
perform
multipl
vitro
cytotox
assay
singl
well
frozen
pbmc
healthi
b
influenzainfect
hlaa
individu
rest
co
incub
overnight
cell
target
cell
isol
cell
mac
split
equal
group
puls
correspond
peptid
includ
one
addit
group
incub
dmso
peptid
sequenc
shown
tabl
puls
target
cell
combinator
label
cell
label
dye
celltrac
violet
celltrac
yellow
celltrack
cmfda
celltrack
deep
red
mix
equal
number
split
two
group
one
group
incub
cell
group
without
cell
incub
co
overnight
analyz
next
day
flow
cytometri
calcul
specif
lysi
target
cell
cognat
cell
p
oneway
anova
holmsidak
multipl
comparison
test
ebo
control
cell
epitop
show
elev
level
challeng
mice
corrobor
cytotox
assay
compar
cell
activ
former
show
potent
cytotox
latter
cytotox
despit
compar
level
express
figur
studi
expand
convent
vivo
cytotox
assay
two
paramet
twentyfour
paramet
function
assay
allow
direct
assess
multipl
cell
specif
simultan
singl
mous
human
pbmc
sampl
lead
us
find
epitopespecif
cell
express
exhibit
concomit
direct
cytotox
importantli
demonstr
phenomenon
limit
three
differ
pathogen
mous
model
iav
malaria
merscov
also
appear
human
pbmc
screen
experiment
known
iav
epitop
observ
rais
concern
cell
studi
applic
valid
epitop
candid
vaccin
studi
current
remain
wide
use
purpos
elicit
product
regard
respond
posit
pathogen
insult
lead
select
potenti
target
vaccin
design
howev
may
mean
cell
induc
kind
epitopebas
vaccin
alway
control
diseas
shown
figur
discrep
direct
indirect
measur
cell
effector
function
influenza
mous
model
splenocyt
vaccin
mice
challeng
lethal
infect
use
measur
epitopespecif
cell
effector
function
direct
vivo
cytotox
indirect
assay
twentythre
differ
peptid
employ
screen
tabl
fulli
util
capabl
multiplex
assay
repres
gate
strategi
assay
shown
bc
result
vaccin
b
unvaccin
c
mice
follow
challeng
shown
epitop
group
within
dash
box
homolog
gray
origin
p
p
p
p
kruskalw
test
dunn
posttest
irrelev
control
red
black
asterisk
refer
correspond
data
multiplex
vivo
assay
respect
frontier
immunolog
wwwfrontiersinorg
tabl
publish
literatur
employ
screen
result
shown
p
p
p
kruskalw
test
dunn
posttest
irrelev
control
ova
red
black
asterisk
refer
correspond
data
multiplex
vivo
assay
respect
simian
immunodefici
viru
vaccinationchalleng
studi
human
iav
trial
although
cytotox
data
obtain
studi
argu
possibl
discrep
product
actual
cytotox
potenti
epitopespecif
cell
may
one
caus
respect
believ
multiplex
cytotox
assay
valid
epitop
candid
term
cytotox
potenti
cognat
cell
particular
approach
robust
tool
reveal
comprehens
pictur
protect
role
cell
stimul
cellbas
vaccin
furthermor
multiplex
cytotox
assay
also
use
evalu
cell
cytotox
respons
cell
therapi
involv
chimer
antigen
receptor
car
cell
cancer
vaccin
multiplex
cytotox
assay
describ
produc
result
compar
convent
singleplex
cytotox
assay
perform
instead
data
shown
offer
sever
advantag
firstli
number
recipi
mice
need
given
experiment
setup
reduc
result
lower
cost
better
complianc
anim
ethic
rule
data
reproduc
across
multipl
epitop
secondli
cell
kill
activ
differ
compart
analyz
simultan
provid
data
use
evalu
efficaci
vaccin
induc
system
mucos
figur
discrep
direct
indirect
measur
cell
effector
function
middl
east
respiratori
syndrom
mer
mous
model
mice
infect
merscovemc
via
intranas
rout
week
mice
challeng
pfu
mouseadapt
strain
merscov
via
intranas
rout
spleen
mice
harvest
stimul
correspond
peptid
presenc
brefeldin
express
cell
splenocyt
quantifi
black
parallel
splenocyt
healthi
donor
mice
use
multiplex
vivo
cytotox
assay
correspond
peptid
transfer
transducedchalleng
recipi
day
postinfect
recipi
splenocyt
harvest
analyz
flow
cytometri
red
p
p
p
p
kruskalw
test
dunn
posttest
irrelev
control
ova
red
black
asterisk
refer
correspond
data
multiplex
vivo
assay
respect
adapt
immun
thirdli
expans
paramet
avail
screen
allow
one
includ
one
irrelev
epitop
cytotox
assay
definit
irrelev
epitop
elicit
destruct
cell
howev
shown
uninfect
cell
also
undergo
apoptosi
necrosi
iav
infect
henc
argu
nonspecif
kill
appli
intend
target
cell
destruct
irrelev
target
cell
act
control
measur
nonspecif
kill
activ
permit
calcul
actual
cellmedi
cytotox
level
express
epitopespecif
cell
wide
use
measur
cell
activ
henc
repres
marker
evalu
efficaci
cell
epitop
express
commonli
use
maker
stain
method
eg
tetram
stain
indirect
method
assess
cell
function
one
would
expect
cell
upregul
product
cytolyt
cognat
target
howev
hiv
set
singlecel
analysi
individu
hivspecif
cell
vitro
reveal
discord
express
cytolyt
potenti
three
differ
mous
model
infect
test
studi
show
discrep
also
occur
epitopespecif
cell
case
discrep
exist
specif
cell
possess
vigor
cytolyt
activ
howev
also
happen
vice
versa
continu
signal
activ
epitopespecif
cell
shown
lead
reduct
cytolyt
potenti
suggest
cell
may
downregul
product
order
maintain
cytolyt
potenti
hand
find
substanti
product
cell
possess
low
cytotox
potenti
cell
merscovinfect
mice
also
unusu
similar
phenomena
could
also
found
human
mechan
behind
yet
determin
mechan
regul
product
cytolyt
potenti
epitopespecif
cell
may
highli
complex
futur
research
topic
need
nevertheless
result
point
disadvantag
reli
sole
product
marker
evalu
cell
activ
particularli
screen
cell
epitop
vaccin
candid
one
may
miss
epitop
use
gener
protect
cell
besid
evalu
pathogenspecif
cell
activ
diseas
set
cautiou
marker
use
assess
believ
multiplex
assay
might
abl
fill
gap
dataset
gener
studi
avail
request
correspond
author
studi
involv
human
particip
